Role of histone acetylation in activation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway by manganese chloride

Manganese neurotoxicity is characterized by Parkinson-like symptoms with degeneration of dopaminergic neurons in the basal ganglia as the principal pathological feature. Manganese neurotoxicity studies may contribute to a good understanding of the mechanism of Parkinson's disease (PD). In this...

Full description

Saved in:
Bibliographic Details
Published inToxicology and applied pharmacology Vol. 336; pp. 94 - 100
Main Authors Zhang, Zhipeng, Guo, Zhenkun, Zhan, Yanting, Li, Huangyuan, Wu, Siying
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Manganese neurotoxicity is characterized by Parkinson-like symptoms with degeneration of dopaminergic neurons in the basal ganglia as the principal pathological feature. Manganese neurotoxicity studies may contribute to a good understanding of the mechanism of Parkinson's disease (PD). In this study, we first confirmed that MnCl2 can promote the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) protein in the nucleus or cytoplasm while increasing the binding activity of Nrf2 and antioxidant response elements, further promoting the expression of downstream target gene heme oxygenase 1 (HO-1) and leading to increase levels of reactive oxygen species (ROS) and reduce the levels of reduced glutathione (GSH). Second, we investigated the role of histone acetylation in the activation of Nrf2/HO-1 pathway by manganese chloride in rat adrenal pheochromocytoma (PC12) cells. Histone acetyltransferase inhibitor (anacardic acid) and histone deacetylase inhibitor (trichostatin A, TSA) were used as pretreatment reagents to adjust the level of histone acetylation. Here, we show that downregulation of histone acetylation can inhibit Mn-induced Nrf2 nuclear translocation and further inhibits the Mn-activated Nrf2/HO-1 pathway. This downregulation also promotes manganese-induced increase of ROS and decrease of GSH in neurons. These results suggest that the downregulation of histone acetylation may play an important role in the neurotoxicity caused by manganese and that TSA may provide new ideas and targets in treating manganese-induced Parkinson's syndrome and PD. •Histone hypoacetylation can inhibit the Mn-induced Nrf2 nuclear translocation.•Histone hypoacetylation can inhibit the effect of Mn-activated Nrf2/HO-1 pathway.•Histone hypoacetylation promotes Mn-induced increase of ROS and decrease of GSH.•The effect of TSA provides new idea for the treatment of Mn-induced disease and PD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-008X
1096-0333
1096-0333
DOI:10.1016/j.taap.2017.10.011